Cargando…
Camrelizumab-Related Lethal Arrhythmias and Myasthenic Crisis in a Patient with Metastatic Thymoma
Immune checkpoint inhibitors (ICIs) have emerged in recent years as promising treatment options for several malignant tumors. However, ICI therapy has also been associated with various immune-related adverse events (irAEs), especially for patients with preexisting autoimmune status, which sometimes...
Autores principales: | Zhang, Bo, Gyawali, Laxman, Liu, Zengzhang, Du, Huaan, Yin, Yuehui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411010/ https://www.ncbi.nlm.nih.gov/pubmed/36032051 http://dx.doi.org/10.1155/2022/4042909 |
Ejemplares similares
-
Pembrolizumab-Induced Myasthenic Crisis with HyperCKemia in a Patient with Thymoma
por: Shin, Ji Hye, et al.
Publicado: (2020) -
Myasthenic crisis appearing after resection of intracardiac ectopic thymoma with superior vena cava syndrome
por: Takebayashi, Satoshi, et al.
Publicado: (2021) -
Myasthenic Crisis In Pregnancy
por: French, David M., et al.
Publicado: (2017) -
Pulmonary Edema in Myasthenic Crisis
por: Anand, Uttara Swati, et al.
Publicado: (2013) -
Chemotherapy-induced myasthenic crisis in thymoma treated with primary chemotherapy with curative intent on mechanical ventilation: a case report and review of the literature
por: Patelli, Giorgio, et al.
Publicado: (2021)